Mutation of the retinoblastoma tumour-suppressor gene (RB) leads to th
e deregulation of many proteins and transcription factors that interac
t with the retinoblastoma gene product (pRB), including members of the
E2F transcription factor family(1,2). As pRB is known to repress E2F
transcriptional activity and overexpression of E2F is sufficient for c
ell cycle progression, it is thought that pRB suppresses growth in par
t by repressing E2F-mediated transcription(3). Previously, we reported
that loss of E2f1 in mice results in tissue-specific tumour induction
and tissue atrophy(4), demonstrating that E2F-1 normally controls gro
wth both positively and negatively in a tissue-specific fashion(4,5).
To determine whether E2F-1 deregulation-as a result of loss of pRB-pro
motes proliferation in vivo, we have tested whether loss of E2f1 inter
feres with the pituitary and thyroid tumorigenesis that occurs in Rb1(
+/-) mice(6-9). We have found that loss of E2f1 reduces the frequency
of pituitary and thyroid tumours, and greatly lengthens the lifespan o
f Rb1(+/-); E2f1(-/-) animals, demonstrating that E2F-1 is an importan
t downstream target of pRB during tumorigenesis. Furthermore. loss of
E2f1 reduces a previously reported strain-dependent difference in Rb1(
+/-) lifespan(9,10), suggesting that E2f1 or an E2F-1-regulated gene a
cts as a genetic modifier between the 129/Sv and C57BL/6 strains.